[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,143,767,552
  • Shares Outstanding, K 941,357
  • Annual Sales, $ 65,179 M
  • Annual Income, $ 20,640 M
  • EBIT $ 33,633 M
  • EBITDA $ 35,630 M
  • 60-Month Beta 0.51
  • Price/Sales 17.79
  • Price/Cash Flow 49.01
  • Price/Book 34.24

Options Overview Details

View History
  • Implied Volatility 31.44% (-1.21%)
  • Historical Volatility 32.43%
  • IV Percentile 20%
  • IV Rank 22.93%
  • IV High 46.75% on 04/15/26
  • IV Low 26.88% on 09/04/25
  • Expected Move (DTE 2) 22.32 (1.83%)
  • Put/Call Vol Ratio 0.76
  • Today's Volume 38,343
  • Volume Avg (30-Day) 50,205
  • Put/Call OI Ratio 1.21
  • Today's Open Interest 373,513
  • Open Int (30-Day) 356,739
  • Expected Range 1,197.96 to 1,242.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $9.47
  • Number of Estimates 4
  • High Estimate $10.07
  • Low Estimate $8.95
  • Prior Year $7.02
  • Growth Rate Est. (year over year) +34.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1,109.15 +10.02%
on 08/03/26
1,238.00 -1.43%
on 08/11/26
+31.70 (+2.67%)
since 07/10/26
3-Month
978.87 +24.66%
on 05/18/26
1,249.45 -2.33%
on 07/07/26
+230.41 (+23.28%)
since 05/12/26
52-Week
644.50 +89.34%
on 08/13/25
1,249.45 -2.33%
on 07/07/26
+580.85 (+90.84%)
since 08/12/25

Most Recent Stories

More News
Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market

Files six new lawsuits as company escalates fight to protect patients

LLY : 1,220.28 (+0.43%)
5 Revealing Analyst Questions From Eli Lilly’s Q2 Earnings Call

5 Revealing Analyst Questions From Eli Lilly’s Q2 Earnings Call

LLY : 1,220.28 (+0.43%)
2 S&P 500 Stocks with Exciting Potential and 1 We Ignore

2 S&P 500 Stocks with Exciting Potential and 1 We Ignore

SYF : 79.41 (+1.20%)
HIG : 137.44 (-1.18%)
LLY : 1,220.28 (+0.43%)
Eli Lilly Stock: Analyst Estimates & Ratings

Eli Lilly's market-beating performance has done little to temper Wall Street's optimism, with analysts continuing to see meaningful upside in the stock.

$SPX : 7,748.50 (+0.26%)
IHE : 102.98 (+0.14%)
LLY : 1,220.28 (+0.43%)
LLY Q2 Deep Dive: Key Products and Pipeline Expansion Offset Revenue Miss

LLY Q2 Deep Dive: Key Products and Pipeline Expansion Offset Revenue Miss

LLY : 1,220.28 (+0.43%)
Stock Indices Fall from Early Highs and Settle Mixed

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.17%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.83%. September...

AMAT : 548.15 (+4.29%)
B : 41.23 (+2.74%)
ANET : 210.50 (+6.39%)
HL : 18.10 (+1.91%)
CDE : 18.80 (+1.18%)
TXN : 276.59 (-1.65%)
$IUXX : 29,742.60 (+0.74%)
AMGN : 416.18 (+0.45%)
ZNU26 : 108-195 (+0.06%)
SHOP : 150.41 (-1.44%)
COMP : 12.73 (+0.32%)
ESU26 : 7,769.25 (-0.02%)
LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs

Eli Lilly shares rally on a fresh DTC partnership with CVS Health. A strong Q2 release and impressive future guidance is driving LLY stock higher as well.

CVS : 94.72 (+1.30%)
LLY : 1,220.28 (+0.43%)
Eli Lilly (LLY) Stock Trades Up, Here Is Why

Eli Lilly (LLY) Stock Trades Up, Here Is Why

LLY : 1,220.28 (+0.43%)
The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic

Hims & Hers Health shares have rallied despite an FTC lawsuit over data sharing and billing practices, as weight-loss drug partnerships and Wall Street's cautious Hold rating shape the stock's outlook...

META : 578.85 (-3.38%)
HIMS : 29.97 (-1.77%)
NVO : 46.39 (-1.65%)
LLY : 1,220.28 (+0.43%)
SNAP : 5.20 (-5.63%)
Eli Lilly (NYSE:LLY) Beats Expectations in Strong Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations

Eli Lilly (NYSE:LLY) Beats Expectations in Strong Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations

LLY : 1,220.28 (+0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure...

See More

Key Turning Points

3rd Resistance Point 1,269.58
2nd Resistance Point 1,248.04
1st Resistance Point 1,234.16
Last Price 1,220.28
1st Support Level 1,198.74
2nd Support Level 1,177.20
3rd Support Level 1,163.32

See More

52-Week High 1,249.45
Last Price 1,220.28
Fibonacci 61.8% 1,018.36
Fibonacci 50% 946.97
Fibonacci 38.2% 875.59
52-Week Low 644.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.